Atezolizumab plus chemotherapy with or without bevacizumab in advanced biliary tract cancer: Results from a randomized proof-of-concept phase II trial (IMbrave151).
- Anthony B. El-Khoueiry
- , Zhenggang Ren
- , Hong Jae Chon
- , Joon Oh Park
- , Jin Won Kim
- , Tiziana Pressiani
- , Daneng Li
- , Lyudmila Zhukova
- , Andrew X. Zhu
- , Ming Huang Chen
- , Stephen Paul Hack
- , Stephanie Wu
- , Bo Liu
- , Xiangnan Guan
- , Shan Lu
- , Yulei Wang
- , Teresa Macarulla
- University of Southern California
- Fudan University
- CHA Bundang Medical Center
- Seoul National University
- IRCCS Istituto Clinico Humanitas - Rozzano (Milano)
- City of Hope National Med Center
- Loginov Moscow Clinical Scientific Center
- Veterans General Hospital-Taipei
- Genentech, Inc
- Vall d'Hebron Institute of Oncology
Research output: Contribution to journal › Review article › peer-review
5
Link opens in a new tab
Scopus
citations